Skip to content

13G/A filed by Vivo Opportunity Fund Holdings, L.P.

Vivo Opportunity Fund Holdings, L.P. and 3 other reporting persons reported 378,484 DRUG shares, 3.8% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 13:00:18 UTC.

Accession
0001213900-26-120152
Filer
CIK 1930214
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
378,484
Percent of class
3.8%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group Vivo Opportunity Fund Holdings, L.P..

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Vivo Opportunity Fund Holdings, L.P.PN378,4840378,4840378,4843.8%
Vivo Opportunity, LLCOO378,4840378,4840378,4843.8%
Vivo Opportunity Cayman Fund, L.P.PN39,395039,395039,3950.4%
Vivo Opportunity Cayman, LLCOO39,395039,395039,3950.4%